SE8501312L - Oral doseringsform for etopsid - Google Patents

Oral doseringsform for etopsid

Info

Publication number
SE8501312L
SE8501312L SE8501312A SE8501312A SE8501312L SE 8501312 L SE8501312 L SE 8501312L SE 8501312 A SE8501312 A SE 8501312A SE 8501312 A SE8501312 A SE 8501312A SE 8501312 L SE8501312 L SE 8501312L
Authority
SE
Sweden
Prior art keywords
dosage form
etopside
oral dosage
etoposide
acid
Prior art date
Application number
SE8501312A
Other languages
Unknown language ( )
English (en)
Other versions
SE8501312D0 (sv
Inventor
S Begum
I Ullah
B C Nunning
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8501312D0 publication Critical patent/SE8501312D0/sv
Publication of SE8501312L publication Critical patent/SE8501312L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SE8501312A 1984-03-19 1985-03-18 Oral doseringsform for etopsid SE8501312L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59114484A 1984-03-19 1984-03-19

Publications (2)

Publication Number Publication Date
SE8501312D0 SE8501312D0 (sv) 1985-03-18
SE8501312L true SE8501312L (sv) 1985-09-20

Family

ID=24365235

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8501312A SE8501312L (sv) 1984-03-19 1985-03-18 Oral doseringsform for etopsid

Country Status (28)

Country Link
JP (1) JPS60209516A (sv)
KR (1) KR850006136A (sv)
AT (1) AT392904B (sv)
AU (1) AU571308B2 (sv)
BE (1) BE901963A (sv)
CA (1) CA1238578A (sv)
CH (1) CH662731A5 (sv)
DE (1) DE3509741A1 (sv)
DK (1) DK164535C (sv)
EG (1) EG17521A (sv)
ES (1) ES8702140A1 (sv)
FI (1) FI84023C (sv)
FR (1) FR2561104B1 (sv)
GB (1) GB2155789B (sv)
GR (1) GR850688B (sv)
IE (1) IE58340B1 (sv)
IL (1) IL74615A (sv)
IT (1) IT1187640B (sv)
LU (1) LU85812A1 (sv)
MY (1) MY101916A (sv)
NL (1) NL8500739A (sv)
NO (1) NO170569C (sv)
NZ (1) NZ211078A (sv)
OA (1) OA07968A (sv)
PT (1) PT80131B (sv)
SE (1) SE8501312L (sv)
YU (1) YU45243B (sv)
ZA (1) ZA851935B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤
JPS61189230A (ja) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd エトポシド製剤
DE3629386A1 (de) * 1986-08-29 1988-03-03 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung
US4927638A (en) * 1986-10-08 1990-05-22 Bristol-Myers Company Etoposide solutions
US5154930A (en) * 1987-03-05 1992-10-13 The Liposome Company, Inc. Pharmacological agent-lipid solution preparation
US5376381A (en) * 1988-02-25 1994-12-27 The Liposome Company, Inc. Integrity protected gelatin
JP2000247911A (ja) * 1999-02-26 2000-09-12 Hisamitsu Pharmaceut Co Inc 大腸用吸収促進剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH580255A5 (sv) * 1974-06-04 1976-09-30 Calinter Sa
DE2452785A1 (de) * 1974-11-07 1976-05-13 Universal Oil Prod Co Verfahren zum betrieb einer verbrennungsmaschine
FR2358144A1 (fr) * 1976-07-13 1978-02-10 Lipha Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
JPS5940137B2 (ja) * 1976-10-14 1984-09-28 武田薬品工業株式会社 経口投与用医薬組成物
FR2410504A1 (fr) * 1977-12-05 1979-06-29 Air Liquide Procede de reglage de securite d'un reacteur chimique et installation de reaction d'oxydation mettant en oeuvre ce procede
DE2809543A1 (de) * 1978-03-06 1979-09-13 Werner Henke Verfahren und vorrichtung zum neutralisieren von gasen bei oel- und gasbohrungen
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤

Also Published As

Publication number Publication date
FI851040L (fi) 1985-09-20
GB2155789B (en) 1987-10-21
ATA81985A (de) 1990-12-15
FI851040A0 (fi) 1985-03-15
DK122285A (da) 1985-09-20
DE3509741A1 (de) 1985-09-26
IT8519897A0 (it) 1985-03-14
ES8702140A1 (es) 1986-12-16
FR2561104A1 (fr) 1985-09-20
FR2561104B1 (fr) 1988-04-08
ZA851935B (en) 1985-10-30
CH662731A5 (de) 1987-10-30
IL74615A0 (en) 1985-06-30
DK164535C (da) 1992-11-30
FI84023C (sv) 1991-10-10
IE58340B1 (en) 1993-09-08
BE901963A (fr) 1985-09-18
GB2155789A (en) 1985-10-02
NO170569B (no) 1992-07-27
YU42085A (en) 1988-02-29
IT1187640B (it) 1987-12-23
GR850688B (sv) 1985-07-08
AU3897585A (en) 1985-09-26
FI84023B (fi) 1991-06-28
JPS60209516A (ja) 1985-10-22
DK164535B (da) 1992-07-13
IL74615A (en) 1988-07-31
PT80131B (pt) 1987-10-20
EG17521A (en) 1990-06-30
PT80131A (en) 1985-04-01
NO851022L (no) 1985-09-20
OA07968A (fr) 1987-01-31
KR850006136A (ko) 1985-10-02
DK122285D0 (da) 1985-03-18
AU571308B2 (en) 1988-04-14
IE850686L (en) 1985-09-19
SE8501312D0 (sv) 1985-03-18
MY101916A (en) 1992-02-15
YU45243B (en) 1992-05-28
NZ211078A (en) 1987-08-31
LU85812A1 (fr) 1985-12-12
ES541370A0 (es) 1986-12-16
NO170569C (no) 1992-11-04
CA1238578A (en) 1988-06-28
AT392904B (de) 1991-07-10
GB8506943D0 (en) 1985-04-24
NL8500739A (nl) 1985-10-16

Similar Documents

Publication Publication Date Title
DE69421918T2 (de) Hochdosierte arzneizusammensetzungen
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
MX171191B (es) Composiciones farmaceuticas de glipizida
IT7849462A0 (it) Corpo di capsula in particolare per una capsula per la somministrazione di sostanze medicamentose come pure procedimento e dispositivo per lasua produzione
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
DE3679722D1 (de) Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung.
DE3067536D1 (en) Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa, and method for administration thereof
IS1564B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
NO953189L (no) Vandig legemiddelpreparat med evne til reversibel varmeherdende gelering
NO177376C (no) Fremgangsmåte for fremstilling av en farmasöytisk doseringsform basert på en tampongtrykkmetode
EP0012639A3 (en) Quinolein-3-carboxylic acid derivatives, process for their preparation, their use in medicines and pharmaceutical compositions containing them
SE8501312L (sv) Oral doseringsform for etopsid
DE3764111D1 (de) Arzneimittelkombination.
IT1151953B (it) Composizione farmaceutica per la cura di affezioni della cavita' orale
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
DE3689254D1 (de) Arzneimittel auf Dextrorphanbasis zur intranasalen Applikation.
SE8705035L (sv) Anvaendning av alkylglycerol
IT8548306A0 (it) Composizione per la preparazione di un medicamento da usare per la cura della piorrea alveolare
ATE212840T1 (de) Oral anzuwendende feste arzneizubereitungen mit modulierter wirkstoffabgabe enthaltend nicorandil und verfahren zu deren herstellung
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
IT1166217B (it) Composizione farmaceutica per la terapia delle sterilita' maschile
MY8500525A (en) Pharmaceutical preparation for administration to the mucosa of the oral or nasal cavity
SE8303012D0 (sv) Farmaceutisk komposition

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8501312-6

Effective date: 19931230

Format of ref document f/p: F